Trial0

Clinical trial · NCT03618186 · ENROLLING_BY_INVITATION · PHASE2

Neuroimaging Study

Sponsor: Mayo Clinic

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

The researchers are trying to gather information and learn more about imaging tests in racially different people who are cognitively normal or have dementia.

Interventions

  • Tau PET scan · COMBINATION_PRODUCT

    Patient will receive a dose of flutaucipir and be scanned appropriately

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

* Male or female African Americans 30 years of age or older
* Subjects who have completed or are scheduled to undergo the neurological evaluation procedures described below.

Exclusion Criteria:

* Subjects unable to lie down without moving for 20 minutes.
* Women who are pregnant or cannot stop breast feeding for 24 hours.
* Claustrophobic patients unable to tolerate the scans.
* Subjects with a prolonged QT interval (as demonstrated by ECG test) cannot participate in the Tau-PET scans.
* Standard safety exclusionary criteria for MRI such as metallic foreign bodies, pacemaker, etc, since the quantitative PET data analysis is based on anatomic criteria that are established uniquely for each subject by registration to his/her MRI.

Sites (2)

  • Mayo Clinic in Florida, Jacksonville, Florida
  • Mayo Clinic Minnesota, Rochester, Minnesota

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2026-06-12.